PLK1 and glioblastoma: Nanomicelles for targeted delivery of PLK1-siRNA for GBM therapy were proposed by Zheng et al. The nanomicelles were prepared by the self-assembly of siRNA-disulfide-poly(N-isopropylacrylamide) diblock copolymers [32].